Similar articles for PMID: 26522948

Year	Number of Results
1996	2
1997	2
1998	4
1999	5
2000	2
2001	1
2002	2
2003	3
2004	3
2005	3
2006	5
2007	4
2008	3
2009	2
2010	2
2011	1
2012	4
2013	3
2014	8
2015	1
2016	1
2017	1
2018	1
2020	2
2024	0

1

Potent complement C3a receptor agonists derived from oxazole amino acids: Structure-activity relationships.

Singh R, Reed AN, Chu P, Scully CC, Yau MK, Suen JY, Durek T, Reid RC, Fairlie DP. Singh R, et al. Bioorg Med Chem Lett. 2015 Dec 1;25(23):5604-8. doi: 10.1016/j.bmcl.2015.10.038. Epub 2015 Oct 23. Bioorg Med Chem Lett. 2015. PMID: 26522948

2

Potent heterocyclic ligands for human complement c3a receptor.

Reid RC, Yau MK, Singh R, Hamidon JK, Lim J, Stoermer MJ, Fairlie DP. Reid RC, et al. J Med Chem. 2014 Oct 23;57(20):8459-70. doi: 10.1021/jm500956p. Epub 2014 Oct 8. J Med Chem. 2014. PMID: 25259874

3

The C3a receptor antagonist SB 290157 has agonist activity.

Mathieu MC, Sawyer N, Greig GM, Hamel M, Kargman S, Ducharme Y, Lau CK, Friesen RW, O'Neill GP, Gervais FG, Therien AG. Mathieu MC, et al. Immunol Lett. 2005 Sep 15;100(2):139-45. doi: 10.1016/j.imlet.2005.03.003. Epub 2005 Mar 25. Immunol Lett. 2005. PMID: 16154494

4

Derivation of ligands for the complement C3a receptor from the C-terminus of C5a.

Halai R, Bellows-Peterson ML, Branchett W, Smadbeck J, Kieslich CA, Croker DE, Cooper MA, Morikis D, Woodruff TM, Floudas CA, Monk PN. Halai R, et al. Eur J Pharmacol. 2014 Dec 15;745:176-81. doi: 10.1016/j.ejphar.2014.10.041. Epub 2014 Oct 30. Eur J Pharmacol. 2014. PMID: 25446428 Free PMC article.

5

Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity.

Rowley JA, Reid RC, Poon EKY, Wu KC, Lim J, Lohman RJ, Hamidon JK, Yau MK, Halili MA, Durek T, Iyer A, Fairlie DP. Rowley JA, et al. J Med Chem. 2020 Jan 23;63(2):529-541. doi: 10.1021/acs.jmedchem.9b00927. Epub 2020 Jan 7. J Med Chem. 2020. PMID: 31910011

6

Selective hexapeptide agonists and antagonists for human complement C3a receptor.

Scully CC, Blakeney JS, Singh R, Hoang HN, Abbenante G, Reid RC, Fairlie DP. Scully CC, et al. J Med Chem. 2010 Jul 8;53(13):4938-48. doi: 10.1021/jm1003705. J Med Chem. 2010. PMID: 20527893

7

Complement C3a binding to its receptor as a negative modulator of Th2 response in liver injury in trichloroethylene-sensitized mice.

Wang F, Zha WS, Zhang JX, Li SL, Wang H, Ye LP, Shen T, Wu CH, Zhu QX. Wang F, et al. Toxicol Lett. 2014 Aug 17;229(1):229-39. doi: 10.1016/j.toxlet.2014.06.841. Epub 2014 Jun 26. Toxicol Lett. 2014. PMID: 24974766

8

Complement factors C3a and C5a have distinct hemodynamic effects in the rat.

Proctor LM, Moore TA, Monk PN, Sanderson SD, Taylor SM, Woodruff TM. Proctor LM, et al. Int Immunopharmacol. 2009 Jun;9(6):800-6. doi: 10.1016/j.intimp.2009.03.002. Epub 2009 Mar 12. Int Immunopharmacol. 2009. PMID: 19285573

9

C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.

Ducruet AF, Hassid BG, Mack WJ, Sosunov SA, Otten ML, Fusco DJ, Hickman ZL, Kim GH, Komotar RJ, Mocco J, Connolly ES. Ducruet AF, et al. J Cereb Blood Flow Metab. 2008 May;28(5):1048-58. doi: 10.1038/sj.jcbfm.9600608. Epub 2008 Jan 16. J Cereb Blood Flow Metab. 2008. PMID: 18197178

10

Synthetic small-molecule complement inhibitors.

Holland MC, Morikis D, Lambris JD. Holland MC, et al. Curr Opin Investig Drugs. 2004 Nov;5(11):1164-73. Curr Opin Investig Drugs. 2004. PMID: 15573867 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

61 results

Results by year